182 related articles for article (PubMed ID: 31913852)
1. Predicting and Designing Epitope Ensemble Vaccines against HTLV-1.
Alam S; Hasan MK; Manjur OHB; Khan AM; Sharmin Z; Pavel MA; Hossain MF
J Integr Bioinform; 2020 Jan; 16(4):. PubMed ID: 31913852
[TBL] [Abstract][Full Text] [Related]
2. Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
Raza MT; Mizan S; Yasmin F; Akash AS; Shahik SM
PLoS One; 2021; 16(4):e0248001. PubMed ID: 33798232
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
Jain S; Baranwal M
J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
[TBL] [Abstract][Full Text] [Related]
4. A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
Slathia PS; Sharma P
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():238-245. PubMed ID: 31300121
[TBL] [Abstract][Full Text] [Related]
5. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
Anwar S; Mourosi JT; Khan MF; Hosen MJ
Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
[TBL] [Abstract][Full Text] [Related]
7. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
8.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract][Full Text] [Related]
9. Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.
Sabah SN; Gazi MA; Sthity RA; Husain AB; Quyyum SA; Rahman M; Islam MR
Interdiscip Sci; 2018 Jun; 10(2):251-260. PubMed ID: 27640170
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T-lymphotropic virus-1 infection.
Pandey RK; Ojha R; Chatterjee N; Upadhyay N; Mishra A; Prajapati VK
J Cell Physiol; 2019 Jun; 234(6):8717-8726. PubMed ID: 30370533
[TBL] [Abstract][Full Text] [Related]
11. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
Kazanji M; Heraud JM; Merien F; Pique C; de Thé G; Gessain A; Jacobson S
J Gen Virol; 2006 May; 87(Pt 5):1331-1337. PubMed ID: 16603536
[TBL] [Abstract][Full Text] [Related]
12. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
13. Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development.
Palanisamy N; Lennerstrand J
Scand J Immunol; 2017 May; 85(5):350-364. PubMed ID: 28273384
[TBL] [Abstract][Full Text] [Related]
14. In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever.
Baral P; Pavadai E; Gerstman BS; Chapagain PP
Sci Rep; 2020 May; 10(1):7667. PubMed ID: 32376973
[TBL] [Abstract][Full Text] [Related]
15. HHV-5 epitope: A potential vaccine candidate with high antigenicity and large coverage.
Kumar N; Singh A; Grover S; Kumari A; Kumar Dhar P; Chandra R; Grover A
J Biomol Struct Dyn; 2019 May; 37(8):2098-2109. PubMed ID: 30044169
[TBL] [Abstract][Full Text] [Related]
16. In silico CD4+, CD8+ & humoral immunity associated antigenic epitope prediction and HLA distribution analysis of HTLV-I.
Bano T; Mohammed Janahi E; Dhasmana A; Lohani M; Haque S; K Mandal R; A Dar S; Jawed A; Wahid M; Akhter N; Y Areeshi M
J BUON; 2018; 23(5):1514-1527. PubMed ID: 30570880
[TBL] [Abstract][Full Text] [Related]
17. In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein.
Zheng J; Lin X; Wang X; Zheng L; Lan S; Jin S; Ou Z; Wu J
Viruses; 2017 May; 9(5):. PubMed ID: 28509875
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-I restricted epitopes in six vaccine candidates of Leishmania tropica using immunoinformatics and molecular dynamics simulation approaches.
Akya A; Farasat A; Ghadiri K; Rostamian M
Infect Genet Evol; 2019 Nov; 75():103953. PubMed ID: 31284043
[TBL] [Abstract][Full Text] [Related]
19. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
[TBL] [Abstract][Full Text] [Related]
20. B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.
Yasmin T; Nabi AH
Scand J Immunol; 2016 May; 83(5):321-37. PubMed ID: 26939891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
